Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee Osteoarthritis
Sponsor: R3 Medical Research
Summary
This is a Pilot Study which is randomized, prospective, open label, dose escalation, non-controlled evaluating safety and feasibility of intra-articular Wharton's Jelly (WJ) allograft will be evaluated in patients suffering with knee osteoarthritis. The participants will be randomized to one of three dosing treatment arms that will consist of one intra-articular knee injection containing either low dose, medium dose or high dose WJ allograft tissue.
Official title: Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for
Key Details
Gender
All
Age Range
30 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2024-10-01
Completion Date
2029-10-01
Last Updated
2024-09-23
Healthy Volunteers
No
Conditions
Interventions
Umbilical Cord Wharton's Jelly Allograft Intra-articular Knee Injection
Direct injection of biologic into the knee joint.
Locations (5)
R3 Anti Aging Scottsdale
Scottsdale, Arizona, United States
R3 Anti Aging Beverly Hills
Beverly Hills, California, United States
Optimal Medical Group
Fresno, California, United States
Scheer Medical Wellness
New York, New York, United States
Dr. Duc (Steve) Le, MD
Cleveland, Texas, United States